证券记录 · 已归档季度
MRNA
Moderna, Inc. · Healthcare · Biotechnology
12被追踪持有人
-2Δ持有人
69.84M持有股份
$1.98B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -14.3% ·
股份流向 -11.4% ·
净新建仓位 -16.7%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +2 | 264.33M | $18.50B | +8 | −5 |
| Q1 2026 | 147 | +3 | 253.55M | $12.87B | +6 | −4 |
| Q4 2025 | 144 | +3 | 257.18M | $7.59B | +5 | −1 |
| Q3 2025 | 18 | +1 | 165.07M | $4.26B | +2 | −2 |
| Q2 2025 | 15 | 0 | 160.48M | $4.43B | +1 | −1 |
| Q1 2025 | 12 | -2 | 69.84M | $1.98B | +1 | −3 |
| Q4 2024 | 14 | -1 | 78.84M | $3.28B | +3 | −4 |
| Q3 2024 | 14 | -2 | 62.86M | $4.20B | +2 | −4 |
| Q2 2024 | 16 | — | 65.32M | $7.75B | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 24.95M | -35.9% | $707.29M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 24.95M | -35.9% | $707.29M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 24.95M | -35.9% | $707.29M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 24.95M | -35.9% | $707.29M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 17.78M | +1.1% | $504.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 7.46M | +3.0% | $210.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 7.46M | +3.0% | $210.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 5.64M | +218.7% | $159.78M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 5.64M | +218.7% | $159.78M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 4.45M | +570.8% | $126.27M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.90M | -26.0% | $82.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.90M | -26.0% | $82.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.90M | -26.0% | $82.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 2.90M | -26.0% | $82.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 2.74M | -30.5% | $77.64M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 1.76M | +128.1% | $49.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 1.76M | +128.1% | $49.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 1.36M | +34.6% | $38.56M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 642.95K | -40.1% | $18.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 642.95K | -40.1% | $18.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Millennium Management ✦ | 148.79K | -86.8% | $4.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 15.25K | 新增 | $415,195 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 15.25K | 新增 | $415,195 | 0.0% | New | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 15.25K | 新增 | $415,195 | 0.0% | New | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 15.25K | 新增 | $415,195 | 0.0% | New | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 15.25K | 新增 | $415,195 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| AQR Capital Management | $415,195 | 0.0% |
| AQR Capital Management | $415,195 | 0.0% |
| AQR Capital Management | $415,195 | 0.0% |
| AQR Capital Management | $415,195 | 0.0% |
| AQR Capital Management | $415,195 | 0.0% |
已清仓
| Bridgewater Associates | $25.19M | 曾为 0.1% |
| Coatue Management | $7.94M | 曾为 0.0% |
| Gotham Asset Management | $2.67M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 717 持有人, 306.78M 股份, $15.39B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据